HepatoPac™ Highlights - Volume 2, September 2012

HepatoPac™ Highlights


In this Newsletter:

New Product

Introducing Rat HepatoPac™
Improved, long-lasting hepatocyte cultures are necessary for long term, low-dose toxicity testing as well as assessment of intrinsic clearance and metabolite profiles of low turnover compounds. Rat HepatoPac provides highly functional enzyme activity of both Phase I & Phase II enzymes for over 4 weeks in culture.


Contact us about Rat HepatoPac

Rat HepatoPac™ Co-cultures:

  • Retain viability for over 4 weeks in vitro
  • Enable evaluation of low clearance compounds
  • Allow chronic toxicity studies
  • Combine with Human HepatoPac to identify species-specific toxicity

 

Company News

 

Hepregen User Group Meeting
Hepregen is pleased to announce its first User Group Meeting scheduled to be held on Nov. 30 at the Hotel Marlowe in Cambridge, MA. This meeting will bring together current and prospective users of the HepatoPac technology. Please join us to share your experiences and learn how other are using the most validated micro-liver platform in the industry. Registration is free, but space is limited.

Click here for more information.

 

Whats New


New Rat HepatoPac™ Model System
Take Toxicology Testing to the NEXT level.





Save the Date

Hepregen User Group Mtg

Date: Nov 30, 2012
Time: 9:00am - 4:00pm
Venue: Hotel Marlowe
City: Cambridge, MA


Meeting up with Hegregen

 

18th North American Regional ISSX Meeting
October 14 - 18, 2012
Dallas, TX

 

While there, visit our Exhibitor Symposium
Tuesday, October 16, 2012 Time: 4:00pm - 5:30pm

Lecture Title:
Evaluation of HepatoPac, a MicroPatterned Co-culture System, for Predicting In Vivo Metabolism


Speaker:
Ryan Takahashi, Associate Scientist, DMPK, Genentech, Inc.